ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

Duke wins Avon-NCI funding.

October 31, 2003

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008